Quarry LP Buys Shares of 6,117 Inogen, Inc. (NASDAQ:INGN)

Quarry LP purchased a new position in shares of Inogen, Inc. (NASDAQ:INGN) during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor purchased 6,117 shares of the medical technology company’s stock, valued at approximately $59,000.

Several other hedge funds have also made changes to their positions in the business. Price T Rowe Associates Inc. MD grew its holdings in shares of Inogen by 5.2% in the first quarter. Price T Rowe Associates Inc. MD now owns 23,868 shares of the medical technology company’s stock valued at $193,000 after purchasing an additional 1,188 shares in the last quarter. Meeder Asset Management Inc. purchased a new position in Inogen in the 2nd quarter valued at approximately $30,000. BNP Paribas Financial Markets grew its stake in shares of Inogen by 13.9% in the third quarter. BNP Paribas Financial Markets now owns 42,137 shares of the medical technology company’s stock worth $409,000 after acquiring an additional 5,131 shares in the last quarter. CWM LLC increased its position in shares of Inogen by 2,185.9% during the second quarter. CWM LLC now owns 6,629 shares of the medical technology company’s stock worth $54,000 after acquiring an additional 6,339 shares during the period. Finally, Meros Investment Management LP increased its position in shares of Inogen by 1.6% during the second quarter. Meros Investment Management LP now owns 397,209 shares of the medical technology company’s stock worth $3,229,000 after acquiring an additional 6,385 shares during the period. Institutional investors and hedge funds own 89.94% of the company’s stock.

Analysts Set New Price Targets

Several research analysts recently commented on INGN shares. StockNews.com cut Inogen from a “buy” rating to a “hold” rating in a research note on Thursday, November 21st. Needham & Company LLC reiterated a “hold” rating on shares of Inogen in a research note on Friday, November 8th.

Inogen Trading Up 0.1 %

Shares of INGN opened at $9.51 on Tuesday. The firm has a market capitalization of $226.53 million, a price-to-earnings ratio of -4.23 and a beta of 1.02. The firm’s fifty day simple moving average is $9.50 and its 200-day simple moving average is $9.70. Inogen, Inc. has a twelve month low of $5.08 and a twelve month high of $13.33.

Inogen Company Profile

Inogen, Inc, a medical technology company, develops, manufactures, and markets portable oxygen concentrators to patients, physicians and other clinicians, and third-party payors in the United States and internationally. Its oxygen concentrators are used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions.